Agilon Health falls after J.P. Morgan downgrades co to 'underweight'

Agilon Health

04/05/2026 15:43

** Shares of senior care platform Agilon Health AGL.N slides 7.5% to $27.35

** J.P. Morgan downgrades AGL to "underweight" from "neutral" with a PT of $21

** Brokerage cites continued elevated medical utilization, saying it is "hesitant to lend the benefit of the doubt" as AGL works through a multi-year turnaround

** Says execution risk remains high for AGL, with management needing to rebuild credibility before investors can underwrite a recovery

** "We expect investors will want to see several consecutive quarters of execution before underwriting the material earnings improvement in 2027+," brokerage says

** J.P. Morgan sees limited near-term upside, expecting the stock to trade range-bound as investors favor peers with clearer narratives

** Including session's moves, AGL up 58.9% YTD

 (Reporting by Kunal Das in Bengaluru)

 ((Kunal.Das2@thomsonreuters.com;))